With the impressive average of 150 mitral repairs annually for the last 16 years (possibly a world record, even more impressive given the population of Portugal), the Coimbra team led by Antunes reflects on six cases of circumflex artery injury, mostly in non-right dominant anatomy as expected.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary Disease - Other
November 15, 2017
June 14, 2017
The authors have examined impedance aggregometry on patients undergoing CABG on DAPT. They examined the impact of cessation on beeding and transfusion and showed a higher level of platelet function led to lower transfusions.
May 12, 2017
A short and readable commentary on monoclonal antibodies and dyslipidaemias, particularly on FOURIER, SPIRE and ODYSSEY trials
March 5, 2017
The authors describe a 10-year experience with extended arteriotomy for endarterectomy of a diffusely diseased LAD, using an internal mammary artery for reconstruction. Perioperative mortality was 1.1% and postoperative MI occurred in 9%. Survival at 5 years was 89% and freedom from acute cardiovascular events was 74%.
January 13, 2017
This article is a propensity matched analysis comparing patients undergoing hybrid coronary revascularization (HCR) with minimally invasive left internal mammary artery to left anterior descending artery (LAD) bypass and percutaneous coronary intervention (PCI) to non-LAD arteries to patients undergoing conventional coronary artery bypass grafting (C
June 25, 2016
A large retrospective study of the UNOS database advances that elevated troponin I in selected cardiac donors is NOT associated with various adverse events. The conclusion is likely to stimulate heated discussions.
April 3, 2016
In a propensity-matched analysis, Rosenblum and colleagues found that hybrid revascularization as compared with coronary artery bypass grafting with either single or bilateral internal mammary artery grafts was superior in terms of secondary short-term outcomes (e.g.
March 11, 2016
The authors provide an excellent overview of the rationale for screening all patients with a new diagnosis of cardiomyopathy for coronary artery disease. This rationale includes the following:
February 18, 2016
An Editorial suggesting that atheroma is here to stay...
November 17, 2015
The authors report on the extended follow-up of Courage Trial patients for up to 15 years. In this trial, patients with chronic stable angina were randomized to medical therapy alone versus PCI plus medical therapy. At extended follow-up, there was no difference in overall survival between the two treatment strategies.